Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.54 |
| ▸ | CTH | P32929 | 1/20 | 0.44 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.44 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | ECE1 | P42892 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MME | P08473 | 3/20 | 0.35 |
| ▸ | ACE | P12821 | 1/20 | 0.35 |
| ▸ | CPA1 | P15085 | 1/20 | 0.35 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL18139583 | 0.98 | EGLN1 (0.52) | EGLN1CTHPLA2G2ATGFBR1ALDH1A1 | |
| Acetic Acid SCHEMBL28463102 | 0.95 | EGLN1 (0.50) | EGLN1CTHPLA2G2ATGFBR1ALDH1A1 | |
| SCHEMBL11139095 | 0.91 | EGLN1 (0.47) | EGLN1CTHPLA2G2ATGFBR1ALDH1A1 | |
| SCHEMBL366720 | 0.91 | EGLN1 (0.47) | EGLN1CTHPLA2G2ATGFBR1ALDH1A1 | |
| SCHEMBL10594427 | 0.86 | EGLN1 (0.52) | EGLN1CTHPLA2G2ATGFBR1ALDH1A1 | |
| SCHEMBL366331 | 0.85 | TGFBR1 (0.42) | EGLN1CTHPLA2G2ATGFBR1ALDH1A1 | |
| Acetic Acid SCHEMBL8397576 | 0.85 | TGFBR1 (0.47) | EGLN1CTHPLA2G2ATGFBR1ALDH1A1 | |
| SCHEMBL28746142 | 0.84 | EGLN1 (0.41) | EGLN1CTHPLA2G2ATGFBR1ALDH1A1 | |
| SCHEMBL27050 | 0.84 | — | — | |
| SCHEMBL15535846 | 0.82 | TGFBR1 (0.39) | EGLN1TGFBR1ALDH1A1TDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 711 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118924675-B | Microneedle patch for myocardial infarction treatment and preparation method thereof | 广州贝奥吉因生物科技股份有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-118949084-B | Conductive hydrogel microneedle patch for myocardial repair and preparation method thereof | 广州贝奥吉因生物科技股份有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-114920892-B | Magnetic heterocyclic amine molecularly imprinted composite material and preparation method and application thereof | 中国烟草总公司郑州烟草研究院 | 2025-03-28 | — | — | CN | claimed |
| CN-119185261-A | Nasal brain targeting nano-odor drug delivery system and application | 沈阳药科大学 | 2024-12-27 | — | — | CN | claimed |
| CN-119081017-A | Polyurethane modified acrylic ester aqueous emulsion and preparation method thereof | 苏州联胜化学有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-118949084-A | Conductive hydrogel microneedle patch for myocardial repair and preparation method thereof | 广州贝奥吉因生物科技股份有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-118924675-A | Microneedle patch for myocardial infarction treatment and preparation method thereof | 广州贝奥吉因生物科技股份有限公司 | 2024-11-12 | — | — | CN | claimed |
| CN-118490637-A | Near-electric neutral polyion compound micelle for delivering gene drugs and small-molecule drugs and preparation and application thereof | 四川大学华西医院 | 2024-08-16 | — | — | CN | claimed |
| EP-4396626-A1 | OPHTHALMIC DEVICES AND METHOD OF MANUFACTURING | Bausch + Lomb Ireland Limited (IE) | 2024-07-10 | — | — | EP | claimed |
| EP-4396616-A1 | OPHTHALMIC DEVICES | Bausch + Lomb Ireland Limited (IE) | 2024-07-10 | — | — | EP | claimed |
| US-5415864-A | Colonic-targeted oral drug-dosage forms based on crosslinked hydrogels containing azobonds and exhibiting PH-dependent swelling | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 1995-05-16 | — | — | US | claimed |
| WO-1995010304-A1 | POLYMER-BOUND CAMPTOTHECIN DERIVATIVES | PHARMACIA S.P.A (IT) | 1995-04-20 | — | — | WO | claimed |
| EP-0544671-A4 | COLONIC-TARGETED ORAL DRUG-DOSAGE FORMS BASED ON CROSSLINKED HYDROGELS CONTAINING AZOBONDS AND EXHIBITING PH-DEPENDENT SWELLING | — | 1993-09-15 | — | — | EP | claimed |
| EP-0544671-A1 | COLONIC-TARGETED ORAL DRUG-DOSAGE FORMS BASED ON CROSSLINKED HYDROGELS CONTAINING AZOBONDS AND EXHIBITING pH-DEPENDENT SWELLING | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 1993-06-09 | — | — | EP | claimed |
| EP-0212959-B1 | SUSTAINED-RELEASE FORMULATION CONTAINING AN AMIN ACID POLYMER WITH A LOWER ALKYL (C1-C4) POLAR SOLVENT | BAUSCH & LOMB INCORPORATED (US) | 1993-03-03 | — | — | EP | claimed |
| EP-0219208-B1 | SUBSTAINED-RELEASE FORMULATION CONTAINING AN AMINO ACID POLYMER | BAUSCH & LOMB INCORPORATED (US) | 1992-06-24 | — | — | EP | claimed |
| WO-1991016057-A1 | COLONIC-TARGETED ORAL DRUG-DOSAGE FORMS BASED ON CROSSLINKED HYDROGELS CONTAINING AZOBONDS AND EXHIBITING pH-DEPENDENT SWELLING | UNIVERSITY OF UTAH (US) | 1991-10-31 | — | — | WO | claimed |
| EP-0328979-A2 | Macroporous ion-selective exchange resins | Henkel Kommanditgesellschaft auf Aktien (DE) | 1989-08-23 | — | — | EP | claimed |
| EP-0124017-B1 | POLYSILOXANE COMPOSITION WITH IMPROVED SURFACE WETTING CHARACTERISTICS AND BIOMEDICAL DEVICES MADE THEREOF | BAUSCH & LOMB INCORPORATED (US) | 1989-07-26 | — | — | EP | claimed |
| US-4172934-A | Acrylic functional aminocarboxylic acids and derivatives as components of pressure sensitive adhesives | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1979-10-30 | — | — | US | claimed |